SQI gains approval for celiac disease test in Canada

02/25/2014 | GenomeWeb Daily News (free registration)

SQI Diagnostics has received the go-ahead in Canada to market its Ig_plex Celiac DGP Panel for clinical lab use. The multiplexed panel, which runs on the company's sqid-X platform, is designed to help clinicians rapidly detect celiac disease by quantifying key biomarkers linked to the illness, CEO Andrew Morris said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC